N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143092 |
| CAS No | NA |
| Mol.F. | C16H15ClN4O4S |
| Mol.Wt. | 394.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143093 |
| CAS No | NA |
| Mol.F. | C16H15ClN4O4S |
| Mol.Wt. | 394.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143094 |
| CAS No | NA |
| Mol.F. | C15H13ClN4O4S |
| Mol.Wt. | 380.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143095 |
| CAS No | NA |
| Mol.F. | C14H13ClN4O4S |
| Mol.Wt. | 368.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143096 |
| CAS No | NA |
| Mol.F. | C13H17ClN2O6S |
| Mol.Wt. | 364.80 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143097 |
| CAS No | NA |
| Mol.F. | C14H19ClN2O6S |
| Mol.Wt. | 378.82 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143098 |
| CAS No | NA |
| Mol.F. | C15H24N2O4 |
| Mol.Wt. | 296.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143099 |
| CAS No | NA |
| Mol.F. | C18H30N2O6 |
| Mol.Wt. | 370.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143100 |
| CAS No | NA |
| Mol.F. | C12H18N2O3 |
| Mol.Wt. | 238.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143101 |
| CAS No | NA |
| Mol.F. | C14H22N2O4 |
| Mol.Wt. | 282.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143102 |
| CAS No | NA |
| Mol.F. | C15H22N2O5 |
| Mol.Wt. | 310.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143103 |
| CAS No | NA |
| Mol.F. | C9H21N3O2 |
| Mol.Wt. | 203.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143104 |
| CAS No | NA |
| Mol.F. | C6H14N2O3 |
| Mol.Wt. | 162.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143105 |
| CAS No | NA |
| Mol.F. | C16H24N2O5 |
| Mol.Wt. | 324.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143106 |
| CAS No | NA |
| Mol.F. | C15H22N2O5 |
| Mol.Wt. | 310.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143107 |
| CAS No | NA |
| Mol.F. | C14H19N2O5 |
| Mol.Wt. | 295.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |